Inter Pharma Public Company Limited
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probio… Read more
Inter Pharma Public Company Limited (IP) - Total Assets
Latest total assets as of September 2025: ฿3.20 Billion THB
Based on the latest financial reports, Inter Pharma Public Company Limited (IP) holds total assets worth ฿3.20 Billion THB as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Inter Pharma Public Company Limited - Total Assets Trend (2016–2024)
This chart illustrates how Inter Pharma Public Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Inter Pharma Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Inter Pharma Public Company Limited's total assets of ฿3.20 Billion consist of 32.5% current assets and 67.5% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 6.1% |
| Accounts Receivable | ฿369.13 Million | 12.2% |
| Inventory | ฿329.91 Million | 10.9% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿204.46 Million | 6.8% |
| Goodwill | ฿477.85 Million | 15.8% |
Asset Composition Trend (2016–2024)
This chart illustrates how Inter Pharma Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inter Pharma Public Company Limited's current assets represent 32.5% of total assets in 2024, a decrease from 85.7% in 2016.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2024, down from 8.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 15.8% of total assets.
Inter Pharma Public Company Limited Competitors by Total Assets
Key competitors of Inter Pharma Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Inter Pharma Public Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Inter Pharma Public Company Limited generates 0.63x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Inter Pharma Public Company Limited generates $ 1.23 in net profit.
Inter Pharma Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.79 | 2.03 | 2.60 |
| Quick Ratio | 1.23 | 1.29 | 1.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿488.30 Million | ฿ 498.77 Million | ฿ 256.26 Million |
Inter Pharma Public Company Limited - Advanced Valuation Insights
This section examines the relationship between Inter Pharma Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.30 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | ฿3.02 Billion |
| Market Capitalization | $35.38 Million USD |
Valuation Analysis
Below Book Valuation: The market values Inter Pharma Public Company Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Inter Pharma Public Company Limited's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Inter Pharma Public Company Limited (2016–2024)
The table below shows the annual total assets of Inter Pharma Public Company Limited from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿3.02 Billion | +2.31% |
| 2023-12-31 | ฿2.95 Billion | -2.43% |
| 2022-12-31 | ฿3.03 Billion | +128.01% |
| 2021-12-31 | ฿1.33 Billion | +76.95% |
| 2020-12-31 | ฿749.95 Million | +42.61% |
| 2019-12-31 | ฿525.88 Million | +173.68% |
| 2018-12-31 | ฿192.15 Million | +83.66% |
| 2017-12-31 | ฿104.62 Million | +30.99% |
| 2016-12-31 | ฿79.87 Million | -- |